Rescue therapy with C1-esterase inhibitor concentrate after emergency coronary surgery for failed PTCA

Intensive Care Medicine

Volumn 24, Issue 6, 1998, Pages 635-638

  Bauernschmitt, R ^a   Bohrer H ^a   Hagl, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

C1 esterase inhibitor; Cardiac surgery; Complement system; Postoperative heart failure; Reperfusion damage

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR;

ADULT; AGED; ARTICLE; CASE REPORT; CORONARY ARTERY SURGERY; COUNTERPULSATION; EMERGENCY SURGERY; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PERFORMANCE; HEART SURGERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; REPERFUSION INJURY; REVASCULARIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMPLEMENT C1 INACTIVATOR PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; TREATMENT FAILURE;

EID: 0031903537     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050629     Document Type: Article

References (10)

1. Forman MB, Kolodgie FD, Jenkins M, Virmani R (1993) Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence. J Am Coll Cardiol 21: 1245-1253
2. Tsao PS, Aoki N, Lefer DJ, Johnson G III, Lefer AM (1990) Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 82: 1402-1412
3. Hack CE, Ogilvie AC, Eisele B, Eerenberg AJM, Wagstaff J. Thijs LG (1993) C1-inhibitor therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med 19: 19-28
4. Buerke M, Murohara T, Lefer AM (1995) Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation 91: 393-402
5. Horstick G, Heimann A, Götze O, Hafner G, Berg O, Boehmer P, Becker P, Darius H, Rupprecht HJ, Loos M, Bhakdi S, Meyer J, Kempski O (1997) Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation 95: 701-708
6. Rossen RD, Swain JL, Michael LH, Weakley S, Giannini E, Entman ML (1985) Selective accumulation of the first component of complement and leukocytes in ischemic canine hearts. Circ Res 57: 119-130
7. Ito BR, Roth DR, Engler RL (1990) Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs. Circ Res 66: 596-607
8. Weisman HF, Bartow T, Leppo M, Marsh HC, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearnon DT (1998) Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146-151
9. Gadeck JE, Hasea SW, Gelfand JA, Santaella M, Wickerhauser M, Triantaphyllopoulos DC, Frank MM (1980) Replacement therapy in hereditary angioedema. Successful treatment of acute episodes of angioedema with partly purified C1-inhibitor. N Engl J Med 302: 542-546
10. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW (1981) Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 304: 447-503